Login / Signup

Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria.

Nausheen AhmedLucy LiPatricio RojasFahrettin CovutJane Reese-KocMerle KolkEhsan MalekLeland L MethenyTimothy O'BrienPaolo CaimiMarcos J deLimaBrenda W Cooper
Published in: Bone marrow transplantation (2021)
Keyphrases
  • stem cells
  • peripheral blood
  • end stage renal disease
  • multiple myeloma
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • room temperature
  • patient reported outcomes
  • mesenchymal stem cells
  • ionic liquid